↓Skip to main content

Presentations

Invited Talks
#

  • Jutla A. “Chatbots are counterfeit people.” Presented at: National Academy of Medicine, 2026 Annual Meeting; Neuroscience, Behavior, Brain Function & Disorders Interest Group: Uses and Misuses of AI in Mental Health: A Look Under the Hood; October 18, 2026; Virtual.

  • Jutla A. “Failures of consumer ‘chatbot’ products and risks for adolescent mental health.” NewYork-Presbyterian Youth Mental Health Symposium: Growing Up Online: Youth Mental Health in the Digital Era; April 30, 2026; New York, NY.

  • Jutla A. “Autism and psychosis: an overview for NRXN1 families.” Presented at: NRXN1 Family & Research Conference; February 21, 2026; Philadelphia, PA.

  • Jutla A. “Shared genetic risk between autism and schizophrenia.” Presented at: NRXN1 Family & Research Conference; February 20, 2026; Philadelphia, PA.

  • Jutla A. “The autism-schizophrenia intersection: genetics, cognition and psychopathology.” Presented at: Lifespan Brain Institute Seminar, Children’s Hospital of Philadelphia Research Institute; February 20, 2026; Philadelphia, PA.

  • Jutla A, Kevelson SD. “Beyond the psychiatric diagnosis: identifying genetic neurodevelopmental disorders in outpatient and inpatient psychiatry.” Presented at: Weill Cornell Medicine Department of Psychiatry, Grand Rounds; January 28, 2026; New York, NY.

  • Jutla A. “Autism and schizophrenia: understanding the intersection.” Presented at: Columbia Department of Psychiatry, Grand Rounds: Early Stage Investigator Series; December 10, 2025; New York, NY.

  • Jutla A. “The intersection of autism spectrum disorder and psychosis.” Presented at: NRXN1 Virtual Research and Family Conference 2024; September 14, 2024; Virtual.

  • Shahamatdar S, Jutla A. “Behavioral disturbances and ADHD in autism.” Presented at: New York City Children’s Center, Grand Rounds; May 9, 2023; Virtual.

  • Jutla A. “Autism and psychosis: background and clinical implications.” Presented at: New York City Children’s Center, Grand Rounds; November 15, 2022; Virtual.

  • Jutla A. “An approach to making a diagnosis of autism spectrum disorder.” Presented at: Lurie Children’s Hospital, Department of Psychiatry; June 17, 2021; Virtual.

  • Jutla A. “Understanding psychosis in autism spectrum disorder.” Presented at: Kennedy Krieger Institute, Center for Autism and Related Disorders, Psychology Seminar; February 22, 2021; Virtual.

  • Jutla A, Walkup JT. “Conceptualization of an adolescent with untreated anxiety of childhood.” Presented at: Northwestern University Feinberg School of Medicine, Psychiatry Grand Rounds; February 14, 2018; Chicago, IL.

  • Jutla A, Lavigne JV. “Killing yourself to live: unpacking the paradox of cancer treatment.” Presented at: Ann & Robert H. Lurie Children’s Hospital, Department of Child & Adolescent Psychiatry, Multidisciplinary Case Conference; September 11, 2017; Chicago, IL. | Slides

  • Ahmed A, Jutla A. “ADHD and related syndromes: an overview.” Presented at: Chicago Public Schools Clinical Staff Professional Development Seminar; August 30, 2017; Chicago, IL.

  • Jutla A, MacKenzie JM. “Making decisions about suicide risk: three cases, three judgments.” Presented at: Ann & Robert H. Lurie Children’s Hospital, Department of Child & Adolescent Psychiatry, Multidisciplinary Case Conference; November 14, 2016; Chicago, IL. | Slides

  • Jutla A, MacKenzie JM. “An approach to the conceptualization and assessment of conversion disorder.” Presented at: 21st Annual Midwest Conference of Child Life Specialists; November 6, 2016; Chicago, IL.

  • Jutla A, MacKenzie JM. “Pediatric conversion disorder: a consultation service perspective.” Presented at: Loyola University Stritch School of Medicine, Psychiatry Grand Rounds; September 1, 2016; Maywood, IL.

  • Jutla A. “Future directions in antidepressant pharmacotherapy.” Presented at: VA Greater Los Angeles Healthcare System, Sepulveda Ambulatory Care Center, Psychiatry Grand Rounds; February 12, 2014; North Hills, CA. | Slides

Conference Presentations
#

* denotes presenting author

Research Findings
#

  • Hamati F*, Sherman S, Liu D, Aurora P, Bruges-Boude A, Embry T, Gorraiz G, Hessel F, Hoyniak C, Huang J, Lenet A, Martell S, Omojokun T, Zhang Y, Girgis RR, Shen E, Jutla A. “Characteristics of responses generated by a large language model chatbot product popular among adolescents to psychotic-like content.” Poster presentation at: American Academy of Child and Adolescent Psychiatry, 2026 Annual Meeting; October 29, 2026; Atlanta, GA. | Poster | DOI

  • Sherman S*, Pereira J, Veenstra-VanderWeele J, Jutla A. “Eating disorders in autistic transition-age youth: insights from the Healthy Minds Study.” Poster presentation at: American Academy of Child and Adolescent Psychiatry, 2026 Annual Meeting; October 29, 2026; Atlanta, GA. | Poster | DOI

  • Shen E*, Hamati F, Donohue MR, Girgis RR, Veenstra-VanderWeele J, Jutla A. “The large-language model chatbot product ChatGPT does not reliably generate appropriate responses to psychotic content.” Oral presentation at: American Academy of Child and Adolescent Psychiatry, 2026 Annual Meeting; Symposium: Large-Language Model Chatbot Products in Clinical Psychiatry: Limitations and Safety Risks; October 29, 2026; Atlanta, GA. | DOI

  • Hamati F*, Sherman S*, Lenet A, Zhang Y, Embry T, Gorraiz G, Huang J, Liu D, Martell S, Aurora P, Bruges-Boude A, Girgis RR, Shen E, Jutla A. “Characteristics of Gemini responses to psychotic prompts.” NewYork-Presbyterian Youth Mental Health Symposium: Growing Up Online: Youth Mental Health in the Digital Era; April 30, 2026; New York, NY. | Poster

  • Shen E*, Sherman S*, Hamati F, Donohue MR, Girgis RR, Veenstra-VanderWeele J, Jutla A. “Evaluating the appropriateness of ChatGPT responses to psychotic prompts.” NewYork-Presbyterian Youth Mental Health Symposium: Growing Up Online: Youth Mental Health in the Digital Era; April 30, 2026; New York, NY. | Poster

  • Jutla A. “Investigating the risk of mental health problems in gender-variant autistic adolescents.” Oral presentation at: American Academy of Child & Adolescent Psychiatry, 2025 Annual Meeting; Symposium: Sex Differences and Gender Variance in Autism: Insights From Simons Powering Autism Research for Knowledge (SPARK) and Big Healthcare Databases; October 21, 2025; Chicago, IL. | Slides | DOI

  • Verdes A*, Bhattachan S, Rockhill C, Minjarez MA, Kim SJ, King B, Palumbo ML, Nowinski L, McDougle CJ, Sanders K, Siecinski SK, Giamberardino S, Gregory SG, Kolevzon A, Veenstra-VanderWeele J, Spanos M, Chandrasekhar T, Sikich L, Jutla A. “Predictors of placebo response in the Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors (SOARS-B).” Poster presentation at: International Society for Autism Research, 2025 Annual Meeting; May 2, 2025; Seattle, WA. | Abstract

  • Pereira J*, Ramos N, Snyder LG, Veenstra-VanderWeele J, Jutla A. “Co-occurring mental health diagnoses in transgender and gender-diverse adolescents with autism spectrum disorder.” Poster presentation at: American Academy of Child and Adolescent Psychiatry, 2023 Annual Meeting; October 28, 2023; New York, NY. | DOI

  • Jutla A*, Veenstra-VanderWeele J. “Clinical characteristics of autistic youth in the SPARK cohort with a co-occurring schizophrenia diagnosis.” Oral presentation at: International Society for Autism Research, 2021 Virtual Annual Meeting; May 3–7, 2021. | Slides

  • Jutla A*, Foss-Feig JH, Donohue MR, Veenstra-VanderWeele J. “Neural correlates of autism spectrum disorder with psychotic-like symptoms in the Adolescent Brain Cognitive Development cohort.” Poster at: International Society for Autism Research, 2020 Annual Meeting; abstract accepted and published online, conference cancelled due to COVID-19 pandemic. | Abstract

  • Jutla A*, Donohue MR, Reed HE, Veenstra-VanderWeele J. “Toward a digital phenotype of autism: an exploratory study using Twitter data.” Poster at: International Society for Autism Research, 2020 Annual Meeting; abstract accepted and published online, conference cancelled due to COVID-19 pandemic. | Abstract

  • Reed HE*, Jutla A, Veenstra-VanderWeele J, Fifer WP. “Sleep disruptions in individuals with 16p11.2 copy number variation.” Poster at: International Society for Autism Research, 2020 Annual Meeting; abstract accepted and published online, conference cancelled due to COVID-19 pandemic. | Abstract

  • Jutla A*, Foss-Feig JH, Donohue MR, Veenstra-VanderWeele J. “Resting-state functional connectivity in youth with co-occurring autism spectrum disorder and psychotic-like symptoms.” Oral presentation at Society of Biological Psychiatry, 75th Annual Scientific Convention (Virtual Meeting); May 22, 2020. | Slides

  • Jutla A*, Foss-Feig JH, Donohue MR, Veenstra-VanderWeele J. “The relationship between autism spectrum disorder and prodromal psychosis in the Adolescent Brain Cognitive Development cohort.” Oral presentation and poster at: American College of Neuropsychopharmacology, 58th Annual Meeting; December 8 & 9, 2019; Orlando, FL. | Slides | Poster | DOI

  • Jutla A. “16p11.2 duplication as a model of psychosis in autism spectrum disorder.” Oral presentation and poster at: American Psychiatric Association, 2019 Annual Meeting; Research Colloquium for Junior Investigators; May 19, 2019; San Francisco, CA. | Slides | Poster

  • Jutla A*, Chung WK, Veenstra-VanderWeele J. “Predictors of psychotic symptoms among 16p11.2 copy number variant carriers.” Poster at: International Society for Autism Research, 2019 Annual Meeting; May 2, 2019; Montreal, Canada. | Poster

  • Jutla A. “Prevalence and correlates of attention-deficit/hyperactivity disorder among youth with 16p11.2 copy number variation.” Oral presentation and poster at: American Professional Society of ADHD and Related Disorders, 2019 Annual Meeting; January 19, 2019; Washington, DC. | Slides | Poster

  • Jutla A*, Wang L, Lavigne J, Yang S, Csernansky J. “Resting-state connectivity in adolescents with psychogenic non-epileptic seizures.” Oral presentation at: American Academy of Child and Adolescent Psychiatry, 65th Annual Meeting; Symposium: Conversion and Anxiety: New Neuroimaging Evidence and Clinical Correlates; October 24, 2018; Seattle, WA. | DOI

  • Jutla A. “Barriers to optimal psychiatric care for adolescents with co-occurring developmental disability and severe mental illness in New York State.” Poster at: American Academy of Child and Adolescent Psychiatry, 65th Annual Meeting; Systems of Care Special Program: Improving Care for Youth with ASD and Intellectual Disabilities; October 22, 2018; Seattle, WA. | Poster

  • Moreno AM*, Jutla A, Weiss AG, MacKenzie JM. “Effectiveness of undergraduate and graduate medical education in preparing pediatricians to manage psychiatric problems.” Poster at: American Academy of Child & Adolescent Psychiatry, 64th Annual Meeting; October 25, 2017; Washington, DC. | DOI

  • Jutla A. “Prenatal antidepressant exposure as a risk factor for autism spectrum disorder: an examination of the evidence.” Poster at: American Academy of Child & Adolescent Psychiatry, 63rd Annual Meeting; October 26, 2016; New York, NY. | Poster | DOI

Panels
#

  • Hamati F, Kouzy R, Clark A, Djordjevic D, Shen E, Jutla A. “Large-language model chatbot products in clinical psychiatry: limitations and safety risks.” Discussant at: American Academy of Child and Adolescent Psychiatry, 2026 Annual Meeting; Symposium; October 29, 2026; Atlanta, GA. | DOI

  • Jutla A. “Shared genetic risk between autism and schizophrenia: early insights from clinical research.” Oral presentation and panel co-chair at: American Academy of Child and Adolescent Psychiatry, 2026 Annual Meeting; Symposium: Emerging Psychosis in Autism: Implications for Risk Assessment, Clinical Care, and Research; October 27, 2026; Atlanta, GA. | Presentation DOI | Panel DOI

  • Pereira J, Bodfish JW, Kenworthy L, Hollander E, Jacob S, Jutla A. “The spectrum of rigidity and compulsivity in autism.” Panel chair at: American Academy of Child and Adolescent Psychiatry, 2024 Annual Meeting; October 18, 2024; Seattle, WA. | DOI

  • Besterman A, Constantino J, Pedapati E, Jutla A, Martin A, Moreno de Luca D. “Clinical and translational implications of a new wave of discovery in neuropsychiatric genetics.” Panel co-chair at: American Academy of Child and Adolescent Psychiatry, 2022 Annual Meeting; James C. Harris, MD, Developmental Neuropsychiatry Forum; October 20, 2022; Toronto, ON.

  • Jutla A. “Carving clinical heterogeneity at its joints: the potential role of copy number variation in understanding autism.” Oral presentation and panel chair at: American Academy of Child and Adolescent Psychiatry, 2021 Virtual Annual Meeting; Symposium: Precision Medicine and Genomically-Guided Treatment in Autism Spectrum Disorder: Are We There Yet?; October 27, 2021. | Presentation DOI | Panel DOI

  • Calhoun A, Jacob S, Jutla A, Pedapati E, Martin A. “The pathophysiology of racial disparities in neurodevelopmental disorders.” Panel co-chair at: American Academy of Child and Adolescent Psychiatry, 2021 Virtual Annual Meeting; James C. Harris, MD, Developmental Neuropsychiatry Forum; October 28, 2021.

  • Whitaker A, Rogers C, Jutla A, Pedapati E. “Understanding the neurodevelopmental consequences of premature birth: key findings and their implications for clinical practice.” Panel co-chair at: American Academy of Child and Adolescent Psychiatry, 2020 Virtual Meeting; James C. Harris, MD, Developmental Neuropsychiatry Forum; October 22, 2020.

  • Jutla A. “Understanding psychosis in autism spectrum disorder: conceptual and practical challenges.” Oral presentation and panel chair at: American Academy of Child and Adolescent Psychiatry, 2020 Virtual Meeting; Clinical Perspectives: Important Co-Occurring Problems in Autism Spectrum Disorder: Strategies for Characterization and Treatment; October 23, 2020. | Slides | Presentation DOI | Panel DOI

  • Jutla A. “Psychosis in autism spectrum disorder.” Oral presentation and panel chair at: American Academy of Child and Adolescent Psychiatry, 66th Annual Meeting; Clinical Perspectives: Complex Presentations of Autism Spectrum Disorder: Beyond the Core Features; October 18, 2019; Chicago, IL. | Slides | Presentation DOI | Panel DOI

Clinical Presentations
#

  • Kevelson SD, Jutla A, Vandana P, Veenstra-VanderWeele J. “Autism genetics in clinical context: enhancing diagnostic clarity and informing multidisciplinary treatment.” Discussant at: American Academy of Child and Adolescent Psychiatry, 2026 Annual Meeting; Clinical Case Conference; October 29, 2026; Atlanta, GA.

  • Shen E, Jutla A. “‘You really think AI is a child?’: anthropomorphization, exploitation, and implications for child psychiatry in Humans in the Loop.” Panel co-chair at: American Academy of Child and Adolescent Psychiatry, 2026 Annual Meeting; Media Theatre: Humans in the Loop; October 27, 2026; Atlanta, GA.

  • Jutla A. “Meeting the psychiatric needs of transgender and gender-diverse autistic youth: considerations for assessment and care.” Oral presentation at: American Academy of Child and Adolescent Psychiatry, 2026 Annual Meeting; Institute: Advances in Characterization and Therapeutics of Autism; October 26, 2026; Atlanta, GA. | DOI

  • Jutla A. “Disseminating mentorship and advanced training opportunities to early career child and adolescent psychiatrists.” Oral presentation at: American Academy of Child and Adolescent Psychiatry, 2021 Virtual Annual Meeting; Clinical Perspectives: Technology to the Rescue During COVID-19 Pandemic: Implementation of Virtual Technologies Opens New Avenues for Clinical Education, Support, and Care of Clinicians Who Provide Care to People Diagnosed With Autism Spectrum Disorder and Intellectual Disability; October 26, 2021. | Slides

  • Tioleco N, Jutla A, Reed HE, Whitaker AH. “Life, Animated: How Disney movies helped a boy with ASD connect.” Presented at: American Academy of Child & Adolescent Psychiatry, 66th Annual Meeting; Media Theatre: Life, Animated; October 15, 2019; Chicago, IL. | Slides

  • Lee E*, Jutla A. “Obsessive-compulsive disorder presenting with catatonia: a case report and systematic review of the literature.” Poster at: American Academy of Child and Adolescent Psychiatry, 65th Annual Meeting; October 25, 2018; Seattle, WA. | DOI

  • Ahmed A, Jutla A*. “Can psychosis-associated creatine kinase-emia be a marker of underlying disease? A case report and review of the literature.” Poster at: American Academy of Child and Adolescent Psychiatry, 65th Annual Meeting; October 24, 2018; Seattle, WA. | Poster | DOI

  • Jutla A*, Smith AM, Folmsbee SS. “Complexities in the neurodevelopmental presentation and psychiatric management of a child with multiple inherited chromosomal abnormalities.” Poster at: American Psychiatric Association, 2018 Annual Meeting; May 6, 2018; New York, NY. | Poster

  • Jutla A*, Ramos N. “An ‘atypical’ case of neuroleptic malignant syndrome.” Poster at: American Academy of Child & Adolescent Psychiatry, 62nd Annual Meeting; October 23, 2015; San Antonio, TX. | Poster